GlassScriptPhysician profile
Debra J Fuller
NPI 1093095663
$3,745.82
in general payments reported to CMS, 2019-2025
19 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $351 · 2022: $805 · 2023: $609 · 2024: $832 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,392.05 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,535.89 | 2021-2025 | |
| Janssen Biotech, INC. | $1,182.72 | 2021-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $202.59 | 2022-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $167.41 | 2023-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.43 | 2021-2024 | Xifaxan, Plenvu |
| Novo Nordisk INC | $122.65 | 2025 | Wegovy |
| Daiichi Sankyo INC. | $93.52 | 2024 | Injectafer |
| Pharmacosmos Therapeutics INC. | $39.22 | 2025 | Monoferric |
| Orphalan INC | $33.56 | 2025 | Cuvrior |
| Pfizer INC. | $30.39 | 2022 | |
| Braintree Laboratories, INC. | $29.76 | 2023-2024 | Sutab |
| Aimmune Therapeutics, INC. | $28.66 | 2025 | Zenpep |
| Merck Sharp & Dohme LLC | $25.05 | 2024 | Dificid |
| Celltrion USA INC. | $24.67 | 2025 | Vegzelma |
| Qol Medical, LLC | $24.01 | 2024 | Sucraid |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $18.75 | 2025 | Livdelzi |
| Digestive Care, INC. | $18.01 | 2024 | Pertzye |
| Intercept Pharmaceuticals, INC. | $15.95 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.